Quarterly report pursuant to Section 13 or 15(d)

Organization and Summary of Significant Accounting Policies - Additional Information (Detail)

v2.4.0.8
Organization and Summary of Significant Accounting Policies - Additional Information (Detail) (Merck KGaA)
6 Months Ended
Jun. 30, 2014
Merck KGaA
 
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]  
Percentage share of eligible worldwide development expenses 70.00%